How much funding has Proteon Therapeutics raised?

Proteon Therapeutics has raised $110.2M in total funding, most recently a Series D round.

Who are Proteon Therapeutics's investors?

Proteon Therapeutics's investors include Omega Funds.

When was Proteon Therapeutics founded?

Proteon Therapeutics was founded in 2001.

Where is Proteon Therapeutics headquartered?

Proteon Therapeutics is headquartered in Waltham, Massachusetts, United States.

What industry is Proteon Therapeutics in?

Proteon Therapeutics operates in Biotech, Healthcare.

How many employees does Proteon Therapeutics have?

Proteon Therapeutics has 11-50 employees.

Proteon Therapeutics

Acquired

Waltham, United States · Founded 2001 · $110.2M raised

Biotech

Healthcare

Headquarters: Waltham, Massachusetts
Employees: 11–50
Founded: 2001
Business Model: B2B

Website: proteontherapeutics.com
Total Funding: $110.2M
Last Round: $45.0M Series DMay 2014
Rounds: 4

About

Proteon Therapeutics is a biopharmaceutical company focused on improving the health of patients with kidney and vascular diseases through the development of novel, first-in-class therapies. Founded in 2001, the company is headquartered in Waltham, Massachusetts.

Summary

Proteon Therapeutics is a Biotech company based in Waltham, United States, founded in 2001. It has raised $110.2M in total across 4 rounds, most recently a $45.0M Series D round in May 2014. Investors include Omega Funds.